|
業務類別
|
Biotechnology |
|
業務概覽
|
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908. |
| 公司地址
| 7750 El Camino Real, Suite 2A, Carlsbad, CA, USA, 92009 |
| 電話號碼
| +1 858 704-4900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.palisadebio.com |
| 員工數量
| 8 |
| Dr. Mitchell Lawrence Jones, M.D.,PhD |
Chief Medical Officer |
美元 415.00K |
15/09/2025 |
| Mr. Ryker Willie |
Senior Vice President, Finance and Corporate Controller |
-- |
22/10/2025 |
| Mr. J. D. Finley |
Director, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
美元 542.00K |
15/09/2025 |
|
|
| Mr. Donald A. Williams |
Chairman of the Board |
15/09/2025 |
| Mr. J. D. Finley |
Director, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
15/09/2025 |
| Mr. Binxian Wei |
Independent Director |
15/09/2025 |
| Dr. Emil Chuang, F.R.A.C.P. |
Independent Director |
09/07/2025 |
|
|
|
|
